June 11, 2026 8:31 am

Author: Ben Rogers

Founder, IBD Movement | Living with Crohn's since 2002

A $36 Billion Promise: What IBD Treatment Growth Means for You

The IBD treatment market is projected to grow from $25.5 billion to nearly $36 billion by the early 2030s, reflecting unprecedented investment in personalized medicine and innovative therapies. This growth represents hope for better treatment options and outcomes for the millions living with Crohn’s disease and ulcerative colitis.

AI-Powered Hope: Personalized Nutrition for IBD Becomes Reality

University of Ottawa researchers have developed an AI-powered tool that creates personalized nutrition plans for IBD patients based on individual genetics, gut bacteria, and health history. This breakthrough could transform how we approach dietary management, moving beyond generic advice to truly individualized care that adapts to each person’s unique biology and symptoms.

Finding Your Food Peace: Navigating Meals with Ulcerative Colitis

Living with ulcerative colitis transforms every meal into a careful negotiation between nourishment and symptoms. While there’s no universal diet that works for everyone with UC, developing a personalized approach that emphasizes anti-inflammatory foods and individual tolerance can help restore a sense of control and comfort around eating.

You Missed

Probiotics and IBD: What 20+ Years of Living with Crohn's Taught Me

Probiotics and IBD: What 20+ Years of Living with Crohn’s Taught Me

May 26, 2026
Week of May 18-24, 2026: 4 IBD research stories worth your attention

Week of May 18-24, 2026: 4 IBD research stories worth your attention

May 26, 2026
Week of May 11-17, 2026: Seven IBD research stories worth your attention

Week of May 11-17, 2026: Seven IBD research stories worth your attention

May 17, 2026